We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-13.83%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$6.51B
AUM Growth
-$1.01B
Cap. Flow
+$139M
Cap. Flow %
2.14%
Top 10 Hldgs %
20.49%
Holding
891
New
87
Increased
331
Reduced
275
Closed
84

Top Sells

Rank Stock Value
1
TSRO
TESARO, Inc.
TSRO
+$32.8M
2
EC icon
Ecopetrol
EC
+$29.1M
3
AET
Aetna Inc
AET
+$20.2M
4
XOM icon
ExxonMobil
XOM
+$19.6M
5
AMGN icon
Amgen
AMGN
+$19.2M

Sector Composition

Rank Sector Weight
1 Healthcare 35.31%
2 Technology 15.37%
3 Financials 11.61%
4 Consumer Discretionary 8.19%
5 Communication Services 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TAP icon
126
Molson Coors Class B
TAP
$7.68B
$12.1M 0.19%
215,226
+8,941
+4% +$550K
HRTX icon
127
Heron Therapeutics
HRTX
$86.3M
$12M 0.18%
463,600
+121,200
+35% +$3.33M
ADP icon
128
Automatic Data Processing
ADP
$100B
$11.9M 0.18%
90,405
-1,296
-1% -$183K
MS icon
129
Morgan Stanley
MS
$337B
$11.7M 0.18%
295,353
-71,396
-19% -$3.12M
NTR icon
130
Nutrien
NTR
$32.7B
$11.6M 0.18%
247,495
+78,243
+46% +$4.08M
CCL icon
131
Carnival Corporation Ltd
CCL
$36.1B
$11.6M 0.18%
234,677
+197,202
+526% +$11.3M
SCI icon
132
Service Corp International
SCI
$11.4B
$11.5M 0.18%
284,813
-5,406
-2% -$235K
EIX icon
133
Edison International
EIX
$30.7B
$11.4M 0.18%
200,847
+11,950
+6% +$743K
LOW icon
134
Lowe's Companies
LOW
$116B
$11.3M 0.17%
122,849
-1,837
-1% -$177K
NAVG
135
DELISTED
Navigators Group Inc
NAVG
$11.3M 0.17%
162,500
+97,500
+150% +$6.76M
ADI icon
136
Analog Devices
ADI
$181B
$11.2M 0.17%
130,481
+88,735
+213% +$7.68M
RETA
137
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$11.2M 0.17%
199,200
+4,000
+2% +$244K
NFLX icon
138
Netflix
NFLX
$292B
$11.2M 0.17%
416,620
+104,550
+34% +$3.13M
ATVI
139
DELISTED
Activision Blizzard
ATVI
$11.1M 0.17%
238,918
+41,005
+21% +$2.46M
EA icon
140
Electronic Arts
EA
$52.4B
$11.1M 0.17%
140,351
+47,550
+51% +$4.36M
CBRE icon
141
CBRE Group
CBRE
$40.8B
$11.1M 0.17%
276,371
-65,852
-19% -$2.72M
CMI icon
142
Cummins
CMI
$91.7B
$10.9M 0.17%
81,308
-70,718
-47% -$9.98M
COF icon
143
Capital One
COF
$124B
$10.8M 0.17%
143,488
+5,765
+4% +$499K
ARNA
144
DELISTED
Arena Pharmaceuticals Inc
ARNA
$10.8M 0.17%
277,800
+85,830
+45% +$3.37M
EXEL icon
145
Exelixis
EXEL
$13.9B
$10.8M 0.17%
547,960
+185,460
+51% +$3.31M
NKE icon
146
Nike
NKE
$61.9B
$10.8M 0.17%
145,079
+9,569
+7% +$716K
XLRN
147
DELISTED
Acceleron Pharma
XLRN
$10.6M 0.16%
242,758
+117,758
+94% +$5.88M
CVS icon
148
CVS Health
CVS
$137B
$10.5M 0.16%
160,602
-6,094
-4% -$455K
UHS icon
149
Universal Health Services
UHS
$9.43B
$10.4M 0.16%
89,627
-7,175
-7% -$902K
FIS icon
150
Fidelity National Information Services
FIS
$21.5B
$10.4M 0.16%
101,855
+39,701
+64% +$4.14M

Similar funds

Candriam SCA's Q4 2018 Portfolio in Review

As of Q4 2018, Candriam SCA held 891 positions worth $6.51B, down 13% from $7.52B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Candriam SCA's Q4 2018 filing shows 87 new, 331 increased, 275 reduced and 84 closed positions. Its largest new stake was Azul: 501,000 shares worth $13.9M. The largest sale was TESARO, Inc., an estimated $32.8M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2018 buy was Azul: 501,000 shares worth $13.9M.
  • Candriam SCA added most to Celgene Corp in Q4 2018, an estimated $60.9M increase.
  • Candriam SCA's biggest Q4 2018 reduction was TESARO, Inc., cutting an estimated $32.8M.
  • Candriam SCA fully exited Aetna Inc in Q4 2018, selling an estimated $20.2M.
  • Candriam SCA's ten largest holdings make up 20% of its $6.51B portfolio in Q4 2018.
  • Candriam SCA opened 87 new positions and closed 84 in Q4 2018.
  • Candriam SCA's portfolio value fell 13% quarter-over-quarter to $6.51B.

Based on Candriam SCA's 13F filing for Q4 2018, filed 14 Feb 2019.